Added to YB: 2026-05-21
Pitch date: 2026-05-19
SRTA [bullish]
Strata Critical Medical, Inc.
+6.33%
current return
Author Info
Independent, deep-dive research on small-cap stocks the market isn’t paying attention to. Sign up for the newsletter.
Company Info
Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States.
Market Cap
$464.6M
Pitch Price
$5.21
Price Target
7.93 (+52%)
Dividend
N/A
EV/EBITDA
502.24
P/E
-27.92
EV/Sales
1.80
Sector
Health Care Providers and Services
Category
value
Strata Critical Medical ($SRTA): Pay less than the Parts. Get HEICO Lite Free.
SRTA: Only US operator running full organ services chain (placement, surgical recovery, NRP, preservation, aviation) under one contract. Q1 rev $67.4M beat $63.7M est, +32% organic Logistics growth, 9.5% adj EBITDA margin, first-ever positive OCF $3.9M & FCF $2.1M. NRP penetration 55.8% of DCD donors (vs 7.3% 3yr ago), yields 50% more usable organs/donor. Trades 1.43x FY26 rev vs USPH 1.91x (closest peer). SOTP: $6.62-$7.93 (+39% mid) from segments at peer multiples + $96M M&A dry powder + NOL + Joby earn-out. Risks: unproven M&A discipline (Keystone 9x vs sub-7x framework), 10% SBC/rev, TMDX competition. Watching: platform deal <7x EBITDA, Logistics GM holds 20%, cross-sell traction, SBC compression. Base re-rate clears without crediting any future deals; if roll-up executes at stated 5.5x multiples, extends to HEICO-lite compounder.
Read full article (32 min)